Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Lung Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Neoplasm Metastasis 2Cholangiocarcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urothelial Bladder Carcinoma 1Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thymoma 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oligometastatic Prostate Cancer 1Neoplasms 1Metastatic Urothelial Cancer 1Melanoma 1Locally Advanced Pancreatic Cancer 1Locally Advanced Cervical Cancer 1Liver Neoplasms 1Liposarcoma 1Kidney Neoplasms 1Gestational Trophoblastic Disease 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Cisplatin 4Paclitaxel 3Radiotherapy 2Carboplatin 2zimberelimab 1pembrolizumab 1camrelizumab 1atezolizumab 1Neoadjuvant Therapy 1Drug Therapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Locally Advanced Cervical Cancer × zimberelimab × Clear all
NCT06055738 2023-09-28

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Tang-Du Hospital

Phase 2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡